| 000 | 01584 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516230623.0 | ||
| 264 | 0 | _c20150831 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a2044-6055 | ||
| 024 | 7 |
_a10.1136/bmjopen-2014-006005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrigg, M J | |
| 245 | 0 | 0 |
_aA study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial). _h[electronic resource] |
| 260 |
_bBMJ open _cAug 2014 |
||
| 300 |
_ae006005 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 |
_aArtemisinins _xtherapeutic use |
| 650 | 0 | 4 | _aArtesunate |
| 650 | 0 | 4 |
_aChloroquine _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria _xdrug therapy |
| 650 | 0 | 4 | _aMalaysia |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMefloquine _xtherapeutic use |
| 650 | 0 | 4 | _aPlasmodium knowlesi |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aWilliam, T | |
| 700 | 1 | _aDhanaraj, P | |
| 700 | 1 | _aMenon, J | |
| 700 | 1 | _aBarber, B E | |
| 700 | 1 | _avon Seidlein, L | |
| 700 | 1 | _aRajahram, G | |
| 700 | 1 | _aPrice, R N | |
| 700 | 1 | _aAnstey, N M | |
| 700 | 1 | _aYeo, T W | |
| 773 | 0 |
_tBMJ open _gvol. 4 _gno. 8 _gp. e006005 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmjopen-2014-006005 _zAvailable from publisher's website |
| 999 |
_c24112907 _d24112907 |
||